Parkinson\'s disease (PD) is the second most common adult-onset progressive neurodegenerative disorder. Severe striatal dopamine loss secondary to the degeneration of dopaminergic neurons in the substantia nigra *pars compacta* (SNc)[@b1] is considered as the main pathological hallmark of PD. The decrease in dopaminergic nigrostriatal terminals, which is typically more pronounced in the posterior aspects of the striatum in the hemisphere contralateral to the most clinically affected body side[@b2], is believed to lead to an imbalance between cortico-basal circuits that regulate movement facilitation and inhibition[@b3].

A related role of the basal ganglia is to implement response selection. Indeed, basal ganglia disorders such as PD are associated with response selection impairments. For example, in the Eriksen Flanker task[@b4] in which participants are asked to respond to the direction of a target arrow, appearing with flanking arrows that point to the same or opposite direction, greater response interference effects were observed in PD patients than in healthy aged controls[@b5][@b6]. However, a number of studies using subliminal stimuli have questioned the assumption that the basal ganglia involvement in motor selection is restricted to situations in which the stimuli are perceived consciously[@b7][@b8][@b9][@b10], by using a subliminal masked prime-arrow paradigm derived from the Eriksen Flanker Task. This task has been intensively used in order to study automatic and unconscious motor processes elicited by external stimuli presented below the threshold of awareness[@b7][@b8][@b9][@b10][@b11][@b12][@b13][@b14][@b15][@b16][@b17][@b18][@b19][@b20][@b21][@b22]. In this task, participants are asked to make rapid button presses with the left or right hand following leftward or rightward pointing arrows, which are preceded by a brief subliminal masked prime arrow. Two consecutive effects can be observed behaviorally when manipulating the direction compatibility between prime and target stimuli and the interstimuli interval (ISI): an initial positive compatibility effect (PCE) at ISI-0 (i.e., shorter RT for compatible than for incompatible trials), followed by a negative compatibility effect (NCE) at longer ISI (i.e., longer RT for compatible than incompatible trials). It is hypothesized that the former results from a prime-induced motor activation while the latter involves inhibition of the prime-induced activation[@b23].

To the best of our knowledge, only two studies from the same group examined the effects of PD on the PCE and NCE[@b9][@b10]. Seiss and Praamstra observed an increased PCE in PD patients relative to healthy controls, while the time course of the NCE seemed to be normal[@b9]. However, the experimental paradigm in Seiss and Praamstra did not include neutral prime stimuli and did not allow prime-induced activation and inhibition processes to be disentangled from facilitation and conflict effects embedded in the task[@b8][@b13]. As it is known that PD patients characteristically show asymmetrical motor symptoms (see above), they also compared the PCE between the least and the most affected hand. By asking the subjects to respond in one block with the right hand and in another with the left hand, they failed to find any differences.

The goal of the present study was to further investigate these priming effects in PD patients using the subliminal masked prime task[@b14][@b23] and three different interstimuli intervals (ISI: 0, 150, 300), which allowed the time course of activation/inhibition processes elicited by visual stimuli to be examined. As compared with the study of Seiss and Praamsta[@b9], we used a longer ISI and added neutral trials to separate facilitation/inhibition from conflict effects across ISIs[@b13].

First, we compared RT data between PD and age-matched controls (see [Table 1](#t1){ref-type="table"} and [Figure 1](#f1){ref-type="fig"} for a summary and a graphical representation of expected compatibility effects). Second, in the patients, we looked for a relationship between RT data and the severity of motor impairment using two complementary approaches: i) by comparing the performance between the least and most clinically affected hand (LAH and MAH, respectively) and ii) by testing for a correlation between behavioral performance and the UPDRS III (Unified Parkinson\'s Disease Rating Scale) motor scores[@b24].

Results
=======

Identification task
-------------------

Results confirmed that the prime stimuli were presented below the threshold of awareness. By taking into account the no-responses, overall participants correctly identified a 33 ms prime on 47% of all trials. This performance is lower than chance level. Accuracy rates for PD patients and age-matched controls was 0.42 (below the chance level) and 0.53 respectively, but the latter did not differ significantly from chance level, *t*(14) = 1.25; p = 0.23. No participant was able to reliably discriminate the prime. These results support the view that prime stimuli were unlikely to be consciously perceived by the subjects during the main task.

Compatibility effects in PD patients and age-matched controls
-------------------------------------------------------------

One PD subject was discarded from statistical analysis because of a large number of errors (more than 70% of errors in one condition). RT data analysis revealed a triple interaction between group, compatibility and ISI ([Figure 2a](#f2){ref-type="fig"}), *F*(4,108) = 3.33; *p* = 0.022; *η*^2^ = 0.11. The ANOVA revealed a main effect of group characterized by longer global reaction time in PD than controls across all conditions, *F*(1,27) = 9.73; *p* = 0.004; *η*^2^ = 0.26 as well as a main effect of compatibility, *F*(2,54) = 18.73; *p* \< 0.001; *η*^2^ = 0.41, accompanied by a significant ISI\*compatibility interaction, *F*(4,108) = 6.34; *p* \< 0.001; *η*^2^ = 0.19. The triple interaction suggests a tendency to an NCE in controls but not in PD patients when increasing ISI duration \[interaction ISI\*compatibility in elderly controls: *F*(4,56) = 9.38; *p* \< 0.001; *η*^2^ = 0.40; interaction ISI\*compatibility in PD patients: *F*(4,52) = 1.15; *p* = 0.34\]. Both group showed the expected PCE at ISI-0, as revealed by the significant main effect of compatibility \[Controls: *F*(2,28) = 22.66, *p* \<0.001; PD: *F*(2,28) = 5.65, *p* = 0.009\]. This compatibility effect persisted in PD patients \[*F*(2,28) = 7.96, *p* = 0.002\], but was attenuated (and did not reach the level of significance anymore) in elderly controls at ISI-150 \[*F*(2,28) = 2.30, *p* = 0.14\]. At ISI-300, none of the groups showed a significant main effect of compatibility \[Controls*:* *p* = 0.38; PD: *p* = 0.15\] (for a graphical representation of compatibility effects, see [Figure 3](#f3){ref-type="fig"}). Statistically, no interaction was found between compatibility and group at ISI-0 (*p* = 0.12) and ISI-150 (*p* = 0.21). However, the compatibility\*group interaction neared significance at ISI-300 (*p* = 0.06).

Concerning the accuracy rate, PD patients made more errors (+3%) than age-matched controls but this difference was not significant. A main effect of compatibility, with a worse accuracy rate in incompatible trials, *F*(2,54) = 3.93; *p* = 0.041; *η*^2^ = 0.13, and a main effect of ISI, *F*(2,54) = 10.27; *p* \< 0.001; *η*^2^ = 0.27 were found, as well as a significant interaction between ISI and compatibility, *F*(2,54) = 8.92; *p* \< 0.001; *η*^2^ = 0.25, but no three-way interaction (*p* = 0.39). However, accuracy rate analysis showed a change toward an NCE for age-matched controls when increasing ISI duration \[controls: *F*(4,56) = 7.77; *p* \< 0.001; *η*^2^ = 0.36\] compared to PD patients. However, there was a trend toward significance in this group (*p* = 0.07) ([Figure 2b](#f2){ref-type="fig"}). Additionally, no interaction was found between compatibility and group at ISI-0 (*p* = 0.96), both group showing the expected PCE.

Effect of lateralized motor impairment
--------------------------------------

The repeated measures ANOVA showed a main effect of compatibility, *F*(2,26) = 9.79; *p* = 0.002; *η*^2^ = 0.43 and the three-way interaction approached significance, *F*(4,52) = 2.48; *p* = 0.06; *η*^2^ = 0.16. There was no main effect of hand. According to our *a priori* hypothesis of an asymmetric deficit in the automatic and unconscious motor activation in PD, the interaction should be especially marked in ISI-0. Indeed, the compatibility\*hand interaction was significant, *F*(2,26) = 3.83; *p* = 0.03; *η*^2^ = 0.23 with an impaired facilitation effect and preserved conflict effect for the MAH (Facilitation = −2 ms; Conflict = 33 ms) in comparison to the LAH (Facilitation = 26 ms; Conflict = −4 ms) \[Facilitation LAH \> Facilitation MAH: *t*(13) = 2.13, *p* = 0.03; Conflict MAH \> Conflict LAH: *t*(13) = 2.66, *p* = 0.01\] ([Figure 4](#f4){ref-type="fig"}). However, there was no significant difference in the PCE (incompatible -- compatible) between the MAH and the LAH. In contrast, the control group did not show any differences in the facilitation and conflict effects between left and right hand responses \[Facilitation right (13 ms) vs. left (22 ms): *p* = 0.36; Conflict right (37 ms) vs. left (23 ms): *p* = 0.35\]. There was no compatibility difference between normal unilateral performances in PD patients and age-matched controls (i.e. facilitation for the LAH in PD vs. facilitation in controls, *p* = 0.61 and conflict for the MAH in PD vs. conflict in controls, *p* = 0.23). The accuracy rate showed a similar tendency but no significant effect was detected.

Correlation analysis in PD patients
-----------------------------------

We tested for a relationship between task performance (global RT, accuracy, compatibility effect) and severity of motor impairment at the time of testing as indexed by the total UPDRS III motor score assessed in the "on" state. We observed a negative correlation between disease severity and accuracy rate, *R* = −0.58; *p* \< 0.05. However, disease severity did not correlate with global RT. Interestingly, the facilitation effect at ISI-0 was negatively correlated to disease severity, *R* = −0.68; *p* \< 0.05, showing a stronger impairment of the automatic motor activation for more severe motor impairment. Additionally, the facilitation effect was negatively linked to the bradykinesia score of the MAH (*R* = −0.65; *p* \< 0.05). Disease duration and levodopa equivalent daily dose did not correlate with any compatibility effects (*p* \> 0.05).

Discussion
==========

The purpose of the present study was to examine the effects of basal ganglia circuit disturbances on automatic and unconscious motor processes using a subliminal visuo-motor task. Age-matched controls showed a classical PCE at ISI-0. This PCE persisted at ISI-150, but its size decreased. At ISI-300, controls showed an NCE (i.e., longer RT and less accuracy for compatible than incompatible trials), albeit not statistically significant ([Figure 2](#f2){ref-type="fig"} and [Figure 3](#f3){ref-type="fig"}). RT differed between PD and controls across ISIs as assessed by a three-way interaction analysis between groups, compatibility and ISIs. Whereas global RT was longer in PD than in controls, group differences in compatibility effects were observed at ISI-150 and ISI-300 during which PD patients showed no reduction in the magnitude of the PCE and no NCE, respectively. Additional group differences emerged when considering RT for neutral trials ([Figure 3](#f3){ref-type="fig"}, middle and right panels). At ISI-0, controls but not PD patients showed evidence for motor response facilitation and conflict. Further analyses revealed differences between left and right hand motor performance in the patients but not in controls. Results showed that normal facilitation and conflict effects could still be observed in the patients for motor responses performed with the LAH and MAH, respectively ([Figure 4](#f4){ref-type="fig"}). The facilitation effect at ISI-0 was negatively related to bradykinesia scores on the UPDRS III. Altogether, these results support the role of basal ganglia circuits in controlling the balance between automatic motor response facilitation and inhibition. The deficit in motor response facilitation elicited by unconsciously perceived visual stimuli may play a role in the pathophysiology of the motor disorder in PD.

We found that PD patients have longer global RT than age-matched controls in response to target stimuli whatever the physical properties of the prime stimulus. The slowness of PD patients in RT tasks, previously reported by different studies[@b25][@b26][@b27][@b28][@b29], is mainly explained by a deficit in movement preparation (i.e. akinesia) rather than a slowness in execution of motor commands. Unlike healthy subjects, PD patients have difficulty in integrating different sources of stimuli for the selection of the most appropriate motor action (i.e., sensorimotor integration)[@b30]. The fact that PD patients are slower in both simple RT task (i.e., with the same response on every trial) and in a choice RT task, supports the hypothesis of a deficit at the level of response initiation[@b26]. At the prime level of the subliminal visuo-motor task, participants cannot consciously prepare the motor response associated with the prime stimulus. However, the motor preparation system is also activated by subliminal stimuli presentation even when no movement must be executed[@b12]. In daily life, various cues in the environment have the potential to trigger associated motor actions. Motor activation triggered by external stimuli is an automatic mechanism through which the simple view of an object is sufficient to partially select the corresponding movement if there is a well-established stimulus-response mapping, with the aim of facilitating motor execution[@b31]. This process is therefore essential for efficient interaction with our environment. PD patients showed an impaired automatic activation of the MAH and the facilitation effect was negatively related to disease severity. Therefore, this automatic and unconscious visuo-motor process may account for the difficulties PD patients have in initiating movements by efficiently integrating environmental stimulation and using this to assist motor program execution. Indeed, it is possible that one of the mechanisms through which the motor preparation system contributes to the control of movement is an efficient motor activation that can occur without conscious perception of the stimuli. However, it is well known that PD patients can take advantage of consciously perceived cues, notably when walking[@b30], suggesting that impaired unconscious sensorimotor integration might be compensated by conscious perception of sensory information.

Basal ganglia circuit dysfunctions induced by PD alter the efficiency of interference control during action selection. This inefficiency stems from a reduced capacity to suppress the automatic activation of conflicting responses that increases interference in a traditional Eriksen Flanker Task[@b5][@b6]. When stimuli are presented below the threshold of awareness, PD patients still exhibit an enhanced susceptibility to interference[@b9]. We had recently underlined distinct roles for unconscious response facilitation and conflict in medial frontal areas[@b13], notably the anterior cingulate cortex and the supplementary motor area, regions that are hypoactivated in PD patients[@b32][@b33]. However, the present results did not confirm the enhanced interference effect observed in previous studies when PD patients are compared with age-matched controls. For the MAH, the facilitation of the prime-induced response was reduced and the conflict was enhanced in comparison to the LAH, but was not significantly greater than in age-matched controls. The fact that there was no significant compatibility difference between normal unilateral performances in PD patients and controls suggests impairment of the automatic activation but not of the interference resolution process. In incompatible trials, response to target stimuli with the LAH was preceded by a deficient prime-induced activation of the MAH. By contrast, when target stimuli were responded to by the MAH, the subliminal prime stimulus efficiently activated the other hand, resulting in a normal conflict effect. An alternative explanation is that the unilateral preserved facilitation is caused by a shift of larger motor activation by subliminal stimuli in the LAH to equal out motor deficits in the MAH that can be generated by a shifted balance in the intercortical inhibition between motor cortices[@b16]. However, our data do not provide direct evidence for this because facilitation effects of the LAH in PD did not significantly differ from those of control participants.

The automatic and unconscious motor inhibition that follows the activation process has been previously investigated in PD patients. Indeed, Seiss and Praamstra[@b10] have first showed that motor inhibition could not be observed at ISI-100 in PD patients or age-matched controls. When analyzing the time course of RT across several ISIs up to 200 ms, they observed a delayed NCE in elderly controls (at ISI-150 and ISI-200 but not at ISI-100). In PD patients, a PCE persisted across all ISIs but its size decreased at the longest ISIs[@b9], resulting in an absent three-way interaction between the compatibility, ISI and group factors. The apparent discrepancy with our significant three-way interaction may be explained by the addition of a longer ISI in our experiment (i.e. 300 ms) in which the stronger between group differences appear. Here, a non-significant smaller PCE was found in ISI-300 for PD in comparison to other ISIs, suggesting maybe a relatively well-preserved pattern, but not as efficient as in age-matched controls who exhibited a tendency toward an NCE. Taken together, these results support the hypothesis of a deficit in automatic and unconscious activation/inhibition motor processes in PD subsequent to a disruption of cortico-basal circuits that influence the selection and the suppression of movements. However, the fact that compatibility effects were not significant at longer ISIs suggests these results should be interpreted with care. Indeed, it is possible that reduced PCEs are the result of some other mechanism such as a passive decay of primed response activation.

Interpretation of these results in terms of a tendency toward an NCE for ISI-150 and 300 is subject to the hypothesis of an inhibitory explanation of the reversed priming effect. However, some authors have suggested that the NCE may arise from processes that are entirely perceptual or even attentional[@b34][@b35]. Indeed, the mask-induced priming hypothesis proposes that the NCE may be produced by positive priming of the alternative response instead of motor inhibition[@b34][@b36]. For example, Lleras and Enns (2004) suggested that the mask contained elements similar to those that made up the primes and targets. Even if the debate is not completely over, it seems that when random line masks are employed, as in the present study, the major source of the NCE remains motor inhibition[@b37].

A possible limitation of this study is that the visuomotor priming task was administered while PD patients were on their usual antiparkinsonian medications. By using the Simon task, Wylie et al.[@b38] have recently shown that PD patients on agonist medication were less proficient at suppressing automatically activated responses compare to when they were tested off them. Additionally, doses of dopamine agonist were negatively linked to response suppression ability. If there is an overlap between conscious and unconscious response inhibition, it is therefore possible that dopamine agonists affect the inhibition of subliminal primed responses. In our study, 6 patients were treated with a dopaminergic agonist in addition to levodopa. Even if the levodopa equivalent daily dose does not correlate with compatibility effects, we cannot infer that medication has no effect on subliminal motor priming. Future studies are needed in order to investigate whether dopaminergic medications influence automatic and unconscious motor inhibition by comparing patients\' performance between 'on' and 'off' states.

Methods
=======

Study population
----------------

The study included 30 participants divided in two experimental groups, PD patients (n = 15) and controls (n = 15) matched for age \[*t*(28) = 0.5, *p* = 0.62\]. In PD, the mean age and disease duration was 67.7 ± 8 years and 11 ± 4 years, respectively. All PD patients were examined on their usual stable dopaminergic medications, that essentially consisted in levodopa monotherapy. They were tested in the morning, usually after having taken the first pill and all reported to be in an "ON" state at the time of testing. Six patients were treated with a dopaminergic agonist in addition to levodopa. Motor impairment was assessed using the motor part (Part III) of the UPDRS[@b24]. The median of the group was 19 ([Table 2](#t2){ref-type="table"}). The left and right upper limb bradykinesia scores (sum of scores from item 23: finger taps + item 24: hand movements + item 25: hand prosupination) were compared using the Wilcoxon test (median score LAH = 3, median score MAH = 5; *p* = 0.004). In order to screen patients for dementia, we administered the Mattis Dementia Rating scale[@b39]. The group mean score was 136 ± 5 (maximal score = 144). No patient was under the cut-off score of 123 that is specific to detect PD dementia[@b40].

The 15 normal elderly subjects (6 men and 9 women) had an average age of 66.1 ± 9 years ([Table 2](#t2){ref-type="table"}). Elderly participants were non-institutionalized, alert, and had no history of neurological problems, alcohol abuse or psychiatric disorders. This study was approved by the ethics committee of the University of Liège and all subjects provided informed written consent. They had normal or corrected vision and normal or corrected hearing.

Stimuli and procedures
----------------------

The visuo-motor task was adapted from that reported in Eimer and Schlagecken[@b14] and D\'Ostilio and Garraux[@b13]. In this task, participants are asked to press a response button as accurately and as quickly as possible with their left or right index finger in response to the presentation of a left or right pointing arrow. In each trial, this target stimulus is briefly preceded by a central prime stimulus. Here, each trial started with a fixation dot presented for 2500 ms, immediately followed by a blank screen of 300 ms and then a prime stimulus displayed for 33 ms. The prime was followed by a mask stimulus consisting of 30 randomly oriented lines within a rectangular area centered on the prime display area on the center of the screen. A new random mask was constructed in each trial. Target stimuli consisted of two double arrows, which appeared for 150 ms, above and below the mask and presented either with the mask (ISI-0), or 150 ms (ISI-150), or 300 ms (ISI-300) after the mask. Trials were labeled as compatible when prime and target arrows pointed in the same direction (prime: ≪, target: ≪; prime: ≫, target: ≫) incompatible when they pointed in opposite directions (prime: ≫, target: ≪; prime: ≪, target: ≫) and neutral when the prime had no response assignment (prime: +, target: ≪ or ≫).

Each subject was trained on a practice block of 30 trials. The main experiment consisted in 432 trials divided into three experimental blocks (ISI-0--ISI-150--ISI-300, always presented in this order). Each block contained an equal number of trials with a compatible, incompatible or neutral prime-target relationship presented in a pseudorandomized order. After the completion of 48 trials, subjects were provided with a 20 sec. rest period during which the mean global reaction time during the last performed block was displayed. The outcome measures were the reaction time (RT) and accuracy in response to the target stimuli.

At the end of the experiment, participants were administered a prime identification task in order to assess whether or not the prime was consciously perceived[@b8]. The task comprised 60 trials. The task display was exactly the same as in the main experiment but participants were asked to guess the direction of the prime arrow stimuli presented before the mask. The percentage of correct responses were calculated and compared to chance level.

Participants were seated at a table in front of a laptop computer at a distance of 50 cm from the screen. They were instructed to maintain central eye fixation and to make a rapid button press with their left or right index finger according to the target arrows direction. Response keys were the *Q* key (for left responses) or the *M* key (for right responses) of a French computer keyboard. Depending on the mechanics of the buttons, there could be some delay between the key press/release and circuit switch on/off that might introduce some variability in RT recordings[@b41]*.* However, this variability is believed to be small and similar across conditions (compatible, incompatible and neutral) and ISIs and should not significantly bias compatibility effects reported in this study. Stimuli were displayed in black on a white background and subtended a visual angle of approximately 1.5° × 1°. Visual stimuli were generated and subject responses recorded by a personal computer using COGENT Cognitive interface software (COGENT 2000, Wellcome Department of Imaging Neuroscience, London, UK) implemented in Matlab 6.1 (Mathworks, Sherborn, MA).

Data analysis
-------------

The statistical analyses were carried out with SPSS version 20.0 (PC version. SPSS Inc., Chicago, IL, USA). Mean RT were calculated on a subject-by-subject basis for each condition (compatible, incompatible and neutral) using trials with correct responses and RT below 1500 ms. Statistical significance was assessed using Analysis of Variance (ANOVA) on mean RT and on accuracy of the within-subject factors ISI (0, 150, 300) and compatibility (compatible, incompatible, neutral) and the between-subjects factor group (PD patients, age-matched controls). Simple effects were calculated for each group. Significant effects were further analyzed using *post hoc* Newman-Keuls tests. Repeated measures ANOVAs on mean RT and accuracy were also performed only on PD patients with ISI, compatibility and hand (more affected, least affected) as within-subjects factors. Simple effects were also calculated in order to examine the interaction between compatibility and hand for each ISI. Planned comparisons were used to examine the facilitation effect (neutral -- compatible) and the conflict effect (incompatible -- neutral) for each hand with the *a priori* hypothesis of an impairment of these processes at ISI-0, related to a deficit of the automatic motor activation in PD patients. The data sphericity was tested using Mauchly\'s test. As sphericity was not respected, we used an adjustment (Huynh-Feldt) before considering the results of the ANOVAs. We estimated effect sizes by using partial eta squared (*η*^2^). A relationship between disease severity, measured by the UPDRS III scores at the time of the experiment, and task performance was evaluated using Spearman\'s rank coefficients.
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![Graphical representation of classical compatibility effects (incompatible RT --compatible RT) in young healthy subjects and expected effects in elderly healthy subjects and Parkinson\'s disease (PD) patients.](srep02095-f1){#f1}

![Mean RTs (a). and accuracy rates (b). for every conditions of each group.\
A global PCE at ISI-0 in Parkinson\'s disease patients (PD) patients and age-matched controls (AC) and a change toward inhibition pattern for AC but not for PD at longer ISI are observed, suggesting an impaired motor inhibition process in PD. Vertical bars represent standard errors.](srep02095-f2){#f2}

![Compatibility effects for each ISIs in Parkinson\'s disease patients (PD) and age-matched controls (AC).\
\* *p* \< 0.05.](srep02095-f3){#f3}

![Comparison between the most (MAH) and least affected hand (LAH) in PD patients for the facilitation effect (Neutral -- compatible RTs) and conflict effect (Incompatible -- neutral RTs).](srep02095-f4){#f4}

###### Summary of subliminal motor processes predicted in healthy elderly controls and PD patients (in comparison to normal effects in young healthy subjects). Expected effect: delay in the occurrence of the NCE for elderly controls (300 ms instead of 150 ms) but no NCE for PD patients

                Young healthy subjects    Healthy elderly subjects   Parkinson\'s disease patients
  ------------ ------------------------- -------------------------- -------------------------------
  **0 ms**             PCE[@b20]            PCE[@b9][@b10][@b20]            PCE[@b9][@b10]
  **150 ms**           NCE[@b20]              PCE[@b10][@b20]               PCE[@b9][@b10]
  **300 ms**    NCE; PCE tendency[@b20]      NCE tendency[@b20]                PCE[@b9]

PCE (positive compatibility effect): TR incompatible trials \> TR compatible trials.

NCE (negative compatibility effect): TR incompatible trials \< TR compatible trials.

###### Demographic and clinical data

  Patients            Age (years)   Gender   Global RT (ms)   Most affected hand   UPDRS part III   Disease duration (years)   Total score MATTIS (max 144)   Medications (LED-mg) [\*](#t2-fn1){ref-type="fn"}
  ------------------ ------------- -------- ---------------- -------------------- ---------------- -------------------------- ------------------------------ ---------------------------------------------------
  1                       70          M           884                left                20                    14                          127                                     400.25
  **2**                   61          M           444                left                13                    9                           136                                       711
  **3**                   62          F           434               right                23                    11                          135                                     364.62
  **4**                   56          F           551               right                24                    7                           142                                     527.25
  **5**                   78          M           479                left                19                    17                          133                                      444.5
  **6**                   50          F           531               right                4                     12                          144                                     1897.5
  **7**                   65          M           394                left                17                    9                           140                                       185
  **8**                   78          M           417               right                30                    14                          128                                     953.75
  **9**                   69          M           588               right                22                    16                          137                                     830.75
  **10**                  76          M           575               right                15                    6                           133                                      627.5
  **11**                  72          M           526                left                25                    14                          136                                     418.75
  **12**                  75          F           523               right                17                    15                          141                                      662.5
  **13**                  67          M           479                left                21                    7                           134                                     452.25
  **14**                  65          F           601               right                18                    7                           138                                       132
  **15**                  72          M           416               right                18                    9                           138                                      248.5
  Control Subjects                                                                                                                                                                     
  **1**                   67          F           453                                                                                                                                  
  **2**                   72          M           470                                                                                                                                  
  **3**                   67          F           430                                                                                                                                  
  **4**                   72          F           412                                                                                                                                  
  **5**                   72          M           425                                                                                                                                  
  **6**                   73          F           440                                                                                                                                  
  **7**                   75          F           493                                                                                                                                  
  **8**                   79          M           451                                                                                                                                  
  **9**                   54          M           401                                                                                                                                  
  **10**                  53          F           351                                                                                                                                  
  **11**                  55          F           399                                                                                                                                  
  **12**                  60          M           406                                                                                                                                  
  **13**                  79          F           447                                                                                                                                  
  **14**                  55          F           393                                                                                                                                  
  **15**                  59          M           460                                                                                                                                  

\*LED = Levodopa Equivalent daily Dose.
